Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL905084 | 0.94 | PDK2 (0.37) | PDK2ESR1ESR2 | |
| SCHEMBL904405 | 0.94 | KDM4E (0.37) | PDK2ESR1ESR2KDM4EMEN1 | |
| SCHEMBL12003630 | 0.94 | KDM4E (0.37) | PDK2ESR1ESR2KDM4EMEN1 | |
| SCHEMBL18090361 | 0.93 | KDM4E (0.36) | PDK2ESR1ESR2KDM4EMEN1 | |
| SCHEMBL18052476 | 0.90 | ESR1 (0.41) | PDK2ESR1ESR2KDM4EMEN1 | |
| SCHEMBL16996126 | 0.90 | ESR1 (0.41) | PDK2ESR1ESR2KDM4EMEN1 | |
| SCHEMBL905053 | 0.89 | PDK2 (0.34) | PDK2ESR1ESR2KDM4EMEN1 | |
| SCHEMBL12469365 | 0.89 | PDK2 (0.34) | PDK2ESR1ESR2KDM4EMEN1 | |
| SCHEMBL17804606 | 0.89 | ESR1 (0.43) | PDK2ESR1ESR2KDM4EMEN1 | |
| SCHEMBL16996422 | 0.89 | ESR1 (0.40) | PDK2ESR1ESR2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180123048-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| WO-2016167491-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS | 덕산네오룩스 주식회사 | 2016-10-20 | — | — | WO | disclosed |
| WO-2012043996-A2 | COMPOUND IN WHICH AMINE DERIVATIVE IS SUBSTITUTED WITH FLUORENE, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL THEREOF | 덕산하이메탈(주) (KR) | 2012-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180123048-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | PDK2 2263/4885ESR1 27/4885ESR2 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.